NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Collections About News Help Login
Back to Results
Intranasal scopolamine preparation and methodA new method and preparation for intranasal delivery of scopolamine provides a safe and effective treatment for motion sickness and other conditions requiring anticholinergic therapy. The preparation can be in the form of aqueous nasal drops, mist spray, gel or oinment. Intranasal delivery of scopolamine has similar bioavailability and effect of intravenous delivery and is far superior to oral dosage. Scopolamine is prepared in a buffered saline solution at the desired dosage rate for effective anticholinergic response.
Document ID
19920002410
Acquisition Source
Legacy CDMS
Document Type
Other - Patent Application
Authors
Putcha, Lakshmi (NASA Lyndon B. Johnson Space Center Houston, TX, United States)
Cintron, Nitza M. (NASA Lyndon B. Johnson Space Center Houston, TX, United States)
Date Acquired
September 6, 2013
Publication Date
September 25, 1991
Subject Category
Aerospace Medicine
Report/Patent Number
NAS 1.71:MSC-21858-1
Report Number: NAS 1.71:MSC-21858-1
Patent Number: NASA-CASE-MSC-21858-1
Patent Application Number: US-PATENT-APPL-SN-765615
Accession Number
92N11628
Distribution Limits
Public
Copyright
Work of the US Gov. Public Use Permitted.
Patent
NASA-CASE-MSC-21858-1
Patent Application
US-PATENT-APPL-SN-765615

Related Records

There are no records associated with this record.
No Preview Available